On 18.12.2009, the commission was awarded by the Federal Joint Committee as a supplementary commissionon for the project A05-19A "cholinesterase inhibitors in the treatment of Alzheimer's Disease" and is currently in progress.
On 18.12.2009, the commission was awarded by the Federal Joint Committee as a supplementary commissionon for the project A05-19A "cholinesterase inhibitors in the treatment of Alzheimer's Disease" and is currently in progress.
